HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Nobuo Yaegashi Selected Research

Androgens

3/2022Co-expression of nuclear heterogeneous nuclear ribonucleic protein K and estrogen receptor α in endometrial cancer.
4/201817β-Hydroxysteroid Dehydrogenase Type 2 Expression Is Induced by Androgen Signaling in Endometrial Cancer.
2/2015The role of 5α-reductase type 1 associated with intratumoral dihydrotestosterone concentrations in human endometrial carcinoma.
11/2006Management of the pain associated with endometriosis: an update of the painful problems.
6/2002Expression of androgen receptor and 5alpha-reductases in the human normal endometrium and its disorders.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Nobuo Yaegashi Research Topics

Disease

89Neoplasms (Cancer)
08/2022 - 07/2002
44Endometrial Neoplasms (Endometrial Cancer)
04/2022 - 06/2002
38Ovarian Neoplasms (Ovarian Cancer)
08/2022 - 07/2002
32Uterine Cervical Neoplasms (Cancer of the Cervix)
03/2022 - 08/2004
28Carcinoma (Carcinomatosis)
01/2022 - 04/2004
18Leiomyosarcoma
03/2020 - 06/2005
17Ovarian Epithelial Carcinoma
01/2021 - 07/2002
14Leiomyoma (Uterine Fibroids)
01/2019 - 05/2002
12Adenocarcinoma
01/2019 - 06/2002
11Neoplasm Metastasis (Metastasis)
04/2021 - 06/2007
11Endometrioid Carcinoma
06/2016 - 06/2003
8Lymphatic Metastasis
04/2022 - 12/2004
8Endometrial Hyperplasia
06/2016 - 06/2002
8Endometriosis
06/2011 - 01/2003
7Breast Neoplasms (Breast Cancer)
03/2022 - 12/2007
7Inflammation (Inflammations)
01/2021 - 09/2005
7Squamous Cell Carcinoma (Epidermoid Carcinoma)
12/2020 - 01/2007
6Uterine Cervical Dysplasia
01/2022 - 03/2003
6Infections
12/2020 - 10/2003
6Sarcoma (Soft Tissue Sarcoma)
01/2019 - 03/2013
6Carcinogenesis
10/2015 - 06/2007
6Carcinosarcoma
06/2015 - 09/2004
5Neutropenia
11/2021 - 09/2003
5Disease Progression
01/2021 - 07/2012
5Residual Neoplasm
11/2020 - 02/2004
5Hypoxia (Hypoxemia)
07/2017 - 02/2010
5Clear Cell Adenocarcinoma
07/2010 - 01/2007
4Hemorrhage
04/2022 - 07/2005
4Mucinous Adenocarcinoma (Mucinous Carcinoma)
01/2022 - 10/2003
4Gestational Diabetes (Gestational Diabetes Mellitus)
11/2019 - 01/2014
3Lymphedema (Milroy Disease)
04/2022 - 09/2012
3Papillomavirus Infections
04/2022 - 07/2012
3Birth Weight (Birth Weights)
01/2022 - 01/2020
3Pre-Eclampsia (Preeclampsia)
01/2021 - 10/2015
3Neural Tube Defects (Exencephaly)
02/2020 - 03/2017
3Fetal Hypoxia
07/2017 - 10/2012
3Ascites
01/2016 - 05/2005

Drug/Important Bio-Agent (IBA)

25Proteins (Proteins, Gene)FDA Link
01/2019 - 11/2003
21Messenger RNA (mRNA)IBA
01/2021 - 06/2002
19Biomarkers (Surrogate Marker)IBA
08/2022 - 06/2008
17PlatinumIBA
08/2022 - 12/2006
16Estrogens (Estrogen)FDA Link
03/2022 - 09/2004
15Paclitaxel (Taxol)FDA LinkGeneric
11/2021 - 10/2003
12Cisplatin (Platino)FDA LinkGeneric
01/2021 - 04/2004
12Biological ProductsIBA
06/2020 - 07/2002
10Carboplatin (JM8)FDA LinkGeneric
01/2021 - 10/2003
8Irinotecan (Camptosar)FDA LinkGeneric
11/2020 - 12/2006
7SteroidsIBA
01/2022 - 07/2002
7Progesterone Receptors (Progesterone Receptor)IBA
07/2014 - 07/2002
5Folic Acid (Vitamin M)FDA LinkGeneric
12/2022 - 03/2017
5Estrogen ReceptorsIBA
03/2022 - 04/2007
5AndrogensIBA
03/2022 - 06/2002
5Bevacizumab (Avastin)FDA Link
11/2021 - 12/2018
5EnzymesIBA
01/2021 - 02/2004
5Pharmaceutical PreparationsIBA
03/2020 - 11/2014
5nedaplatinIBA
08/2016 - 01/2007
5CurcuminIBA
04/2014 - 07/2011
4VaccinesIBA
01/2022 - 10/2016
4DNA (Deoxyribonucleic Acid)IBA
11/2021 - 11/2011
4CeramidesIBA
01/2021 - 01/2015
4Indicators and Reagents (Reagents)IBA
01/2020 - 02/2004
4taxaneIBA
06/2019 - 01/2011
4Doxorubicin (Adriamycin)FDA LinkGeneric
06/2019 - 01/2007
4TOR Serine-Threonine KinasesIBA
02/2018 - 01/2012
4Transcription Factors (Transcription Factor)IBA
09/2015 - 10/2005
4Hormones (Hormone)IBA
02/2015 - 12/2008
4AntibodiesIBA
10/2012 - 03/2003
4Progestins (Progestagens)IBA
07/2011 - 06/2003
4Aromatase (CYP19)IBA
10/2009 - 04/2008
4Protein Isoforms (Isoforms)IBA
12/2008 - 07/2002
4Gonadotropin-Releasing Hormone (GnRH)FDA Link
04/2007 - 05/2002
4Monoclonal AntibodiesIBA
05/2005 - 10/2003
3ORALIT (ORS)IBA
01/2022 - 12/2019
3liposomal doxorubicin (Doxil)FDA Link
11/2021 - 05/2014
3LipopolysaccharidesIBA
01/2021 - 01/2011
32- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA
11/2020 - 12/2006
3Small Interfering RNA (siRNA)IBA
06/2020 - 06/2007
3MicroRNAs (MicroRNA)IBA
01/2020 - 01/2010
3Phosphotransferases (Kinase)IBA
01/2018 - 06/2007
3Oxygen (Dioxygen)IBA
07/2017 - 10/2012
3CalponinsIBA
01/2017 - 06/2012
3AntigensIBA
07/2016 - 05/2005

Therapy/Procedure

54Therapeutics
08/2022 - 05/2002
40Drug Therapy (Chemotherapy)
04/2022 - 09/2003
27Hysterectomy
04/2022 - 02/2004
18Lymph Node Excision (Lymph Node Dissection)
04/2022 - 02/2004
12Radiotherapy
04/2022 - 06/2008
9Chemoradiotherapy
01/2022 - 06/2008
8Operative Surgical Procedures
01/2021 - 01/2006
8Salpingo-oophorectomy
11/2017 - 02/2004
7Trachelectomy
01/2021 - 04/2011
6Aftercare (After-Treatment)
12/2019 - 08/2002
5Adjuvant Chemotherapy
12/2019 - 12/2006
5Hormone Replacement Therapy (Therapy, Hormone Replacement)
01/2019 - 12/2007
5Laparotomy
01/2019 - 02/2003
4Combination Drug Therapy (Combination Chemotherapy)
01/2021 - 09/2004
3Kampo Medicine (Kampo)
05/2021 - 04/2012
3Neoadjuvant Therapy
01/2020 - 08/2012
3Uterine Myomectomy
10/2018 - 07/2003
3Cesarean Section (Caesarean Section)
07/2017 - 07/2005